Chetan G. Kumar
Dehra Dun, UL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Comparison of the standard McCoy laryngoscope and video-assisted McCoy laryngoscope for laryngoscopy and intubation in patients with simulated difficult airway.
Journal: Indian journal of anaesthesia
Published: December 25, 2025
Corrigendum to "Inhibition of mycobacteria proliferation in macrophages by diaryl ether derivatives of Dehydrozingerone compound and repurposed drugs (Rebamipide, Sofalcone) via NF-κB pathway inhibition" [Tuberculosis, 155(2025), 102706].
Journal: Tuberculosis (Edinburgh, Scotland)
Published: December 20, 2025
LC-MS/MS-based discovery of new cytochalasin from fungus Rosellinia sanctae-cruciana.
Journal: Natural product research
Published: September 29, 2025
Polycystic ovary syndrome (PCOS): current insights, emerging therapeutics, and future treatment strategies.
Journal: Inflammopharmacology
Published: September 18, 2025
Inhibition of mycobacteria proliferation in macrophages by diaryl ether derivatives of Dehydrozingerone compound and repurposed drugs (Rebamipide, Sofalcone) via NF-κB pathway inhibition.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: July 04, 2025
Novel Semisynthetic Derivative of Dehydrozingerone (DHZ-15) Modulates Lipopolysaccharide-Stimulated Macrophages by Targeting the NF-κB/p65 Pathway and In Vivo Evaluation in a Sepsis BALB/c Model.
Journal: Clinical and experimental pharmacology & physiology
Published: April 08, 2025
Anti-Inflammatory Activity of Novel Dehydrozingerone-6 (DHZ-6) Through Modulation of iNOS, COX-2, and NF-κB/p65 in LPS-Stimulated Macrophages and In Vivo Acute Lung Injury Murine Model.
Journal: Journal of applied toxicology : JAT
Published: April 06, 2025
Anti-Cancer Potential of Dehydrozingerone's Phenoxy-Acetamide Derivatives: Discovery of a Potent Lead with Dual Anti-Proliferative and Anti-Metastatic Activities.
Journal: Bioorganic chemistry
Published: December 23, 2024
Targeting InhA in drug-resistant Mycobacterium tuberculosis: potent antimycobacterial activity of diaryl ether dehydrozingerone derivatives.
Journal: Archives of microbiology
Published: November 12, 2024
Scoparone chemical modification into semi-synthetic analogues featuring 3-substitution for their anti-inflammatory activity.
Journal: Molecular diversity
Published: April 04, 2023
Last Updated: 09/26/2026